60 - Stanley A. Plotkin Lecture in Vaccinology Award

Friday, October 1, 2021

9:30 AM - 10:00 AM EDT

Moderator(s)

Kristina Bryant, MD, FPIDS

Professor of Pediatrics
University of Louisville and Norton Children's
Louisville, KY, United States

Gilead (Individual(s) Involved: Self): Grant/Research Support; Pfizer (Individual(s) Involved: Self): Grant/Research Support
David Hyun, MD

Project Director
Antibiotic Resistance Project
The Pew Charitable Trusts
McLean, VA, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Speaker(s)

William Gruber, MD

SVP Vaccine Clinical Research and Development
Worldwide Research, Development and Medical
Pfizer Inc
Pearl River, NY, United States

Pfizer (Individual(s) Involved: Self): Employee, Shareholder

Participants should be aware of the following financial/non-financial relationships:

Kristina Bryant, MD, FPIDS: Gilead (Individual(s) Involved: Self): Grant/Research Support; Pfizer (Individual(s) Involved: Self): Grant/Research Support

David Y. Hyun, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

William C. Gruber, MD: Pfizer (Individual(s) Involved: Self): Employee, Shareholder

No CME or MOC credits

No CPE credits

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the structure and function of mRNA vaccines against COVID-19
discuss a phase 1/2/3 strategy to demonstrate safety, immune response, and efficacy for a candidate mRNA COVID-19 vaccine
summarize a comprehensive vaccine clinical development plan to address ongoing challenges of the COVID-19 pandemic

Presentations:

COVID-19 Vaccine: From Hope to Reality in 9 Months
Speaker: William C. Gruber, MD – Pfizer Inc